0001104659-23-058580.txt : 20230510 0001104659-23-058580.hdr.sgml : 20230510 20230510181057 ACCESSION NUMBER: 0001104659-23-058580 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230510 FILED AS OF DATE: 20230510 DATE AS OF CHANGE: 20230510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calais Philippe CENTRAL INDEX KEY: 0001693728 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40363 FILM NUMBER: 23908082 MAIL ADDRESS: STREET 1: C/O MARINA BIOTECH, INC. STREET 2: 17870 CASTLETON STREET, SUITE 250 CITY: CITY OF INDUSTRY STATE: CA ZIP: 91748 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcode Therapeutics, Inc. CENTRAL INDEX KEY: 0001829635 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811065054 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-301-6857 MAIL ADDRESS: STREET 1: 6 LIBERTY SQUARE STREET 2: #2382 CITY: BOSTON STATE: MA ZIP: 02109 4 1 tm2315294-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-05-10 0 0001829635 Transcode Therapeutics, Inc. RNAZ 0001693728 Calais Philippe C/O TRANSCODE THERAPEUTICS, INC. 6 LIBERTY SQUARE, #2382 BOSTON MA 02109 1 0 0 0 0 Stock Option (Right to Buy) 0.2985 2023-05-10 4 A 0 9500 0 A 2033-05-09 Common Stock 9500 9500 D The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 10, 2024 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time. /s/ Thomas A. Fitzgerald, as Attorney-in-Fact 2023-05-10